nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—CHRNA2—epilepsy syndrome	0.515	0.737	CbGaD
Gallamine Triethiodide—CHRM2—epilepsy syndrome	0.184	0.263	CbGaD
Gallamine Triethiodide—CHRNA2—forebrain—epilepsy syndrome	0.00111	0.11	CbGeAlD
Gallamine Triethiodide—ACHE—telencephalon—epilepsy syndrome	0.000823	0.0819	CbGeAlD
Gallamine Triethiodide—CHRM2—forebrain—epilepsy syndrome	0.000662	0.0658	CbGeAlD
Gallamine Triethiodide—ACHE—medulla oblongata—epilepsy syndrome	0.000647	0.0643	CbGeAlD
Gallamine Triethiodide—CHRNA2—head—epilepsy syndrome	0.000635	0.0632	CbGeAlD
Gallamine Triethiodide—CHRM2—telencephalon—epilepsy syndrome	0.000608	0.0605	CbGeAlD
Gallamine Triethiodide—CHRNA2—nervous system—epilepsy syndrome	0.000602	0.0599	CbGeAlD
Gallamine Triethiodide—ACHE—midbrain—epilepsy syndrome	0.000591	0.0588	CbGeAlD
Gallamine Triethiodide—CHRNA2—central nervous system—epilepsy syndrome	0.00058	0.0577	CbGeAlD
Gallamine Triethiodide—ACHE—spinal cord—epilepsy syndrome	0.000577	0.0574	CbGeAlD
Gallamine Triethiodide—CHRNA2—cerebellum—epilepsy syndrome	0.000567	0.0564	CbGeAlD
Gallamine Triethiodide—CHRNA2—brain—epilepsy syndrome	0.00046	0.0458	CbGeAlD
Gallamine Triethiodide—ACHE—cerebellum—epilepsy syndrome	0.000457	0.0455	CbGeAlD
Gallamine Triethiodide—CHRM2—head—epilepsy syndrome	0.000379	0.0377	CbGeAlD
Gallamine Triethiodide—ACHE—brain—epilepsy syndrome	0.000371	0.037	CbGeAlD
Gallamine Triethiodide—CHRM2—nervous system—epilepsy syndrome	0.000359	0.0357	CbGeAlD
Gallamine Triethiodide—CHRM2—central nervous system—epilepsy syndrome	0.000346	0.0344	CbGeAlD
Gallamine Triethiodide—CHRM2—brain—epilepsy syndrome	0.000275	0.0273	CbGeAlD
Gallamine Triethiodide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000127	0.000697	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000127	0.000696	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000127	0.000695	CcSEcCtD
Gallamine Triethiodide—Malaise—Valproic Acid—epilepsy syndrome	0.000127	0.000693	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000126	0.000688	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vigabatrin—epilepsy syndrome	0.000126	0.000688	CcSEcCtD
Gallamine Triethiodide—Urticaria—Clonazepam—epilepsy syndrome	0.000125	0.000685	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Gabapentin—epilepsy syndrome	0.000125	0.000684	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000125	0.000682	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Clonazepam—epilepsy syndrome	0.000124	0.000681	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Clonazepam—epilepsy syndrome	0.000124	0.000681	CcSEcCtD
Gallamine Triethiodide—Fatigue—Lamotrigine—epilepsy syndrome	0.000124	0.000681	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Pregabalin—epilepsy syndrome	0.000124	0.000681	CcSEcCtD
Gallamine Triethiodide—Urticaria—Phenytoin—epilepsy syndrome	0.000124	0.00068	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000124	0.00068	CcSEcCtD
Gallamine Triethiodide—Pruritus—Vigabatrin—epilepsy syndrome	0.000124	0.000678	CcSEcCtD
Gallamine Triethiodide—Asthenia—Diazepam—epilepsy syndrome	0.000124	0.000677	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Phenytoin—epilepsy syndrome	0.000124	0.000677	CcSEcCtD
Gallamine Triethiodide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000124	0.000676	CcSEcCtD
Gallamine Triethiodide—Pain—Lamotrigine—epilepsy syndrome	0.000123	0.000675	CcSEcCtD
Gallamine Triethiodide—Nausea—Acetazolamide—epilepsy syndrome	0.000123	0.000675	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000123	0.000673	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000123	0.000673	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000123	0.000673	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000123	0.000673	CcSEcCtD
Gallamine Triethiodide—Cough—Valproic Acid—epilepsy syndrome	0.000123	0.000671	CcSEcCtD
Gallamine Triethiodide—Vomiting—Propofol—epilepsy syndrome	0.000122	0.000671	CcSEcCtD
Gallamine Triethiodide—Pruritus—Diazepam—epilepsy syndrome	0.000122	0.000668	CcSEcCtD
Gallamine Triethiodide—Rash—Propofol—epilepsy syndrome	0.000121	0.000665	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Propofol—epilepsy syndrome	0.000121	0.000664	CcSEcCtD
Gallamine Triethiodide—Headache—Propofol—epilepsy syndrome	0.000121	0.000661	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00012	0.000659	CcSEcCtD
Gallamine Triethiodide—Vomiting—Midazolam—epilepsy syndrome	0.00012	0.000656	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00012	0.000656	CcSEcCtD
Gallamine Triethiodide—Asthenia—Felbamate—epilepsy syndrome	0.00012	0.000655	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Valproic Acid—epilepsy syndrome	0.00012	0.000655	CcSEcCtD
Gallamine Triethiodide—Chest pain—Valproic Acid—epilepsy syndrome	0.00012	0.000655	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000119	0.000651	CcSEcCtD
Gallamine Triethiodide—Rash—Midazolam—epilepsy syndrome	0.000119	0.000651	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000119	0.00065	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Midazolam—epilepsy syndrome	0.000119	0.00065	CcSEcCtD
Gallamine Triethiodide—Urticaria—Carbamazepine—epilepsy syndrome	0.000119	0.000649	CcSEcCtD
Gallamine Triethiodide—Vomiting—Levetiracetam—epilepsy syndrome	0.000118	0.000648	CcSEcCtD
Gallamine Triethiodide—Headache—Midazolam—epilepsy syndrome	0.000118	0.000647	CcSEcCtD
Gallamine Triethiodide—Pruritus—Felbamate—epilepsy syndrome	0.000118	0.000646	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000118	0.000646	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000118	0.000646	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Diazepam—epilepsy syndrome	0.000118	0.000646	CcSEcCtD
Gallamine Triethiodide—Rash—Levetiracetam—epilepsy syndrome	0.000117	0.000643	CcSEcCtD
Gallamine Triethiodide—Anaemia—Pregabalin—epilepsy syndrome	0.000117	0.000642	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000117	0.000642	CcSEcCtD
Gallamine Triethiodide—Asthenia—Zonisamide—epilepsy syndrome	0.000117	0.000642	CcSEcCtD
Gallamine Triethiodide—Headache—Levetiracetam—epilepsy syndrome	0.000117	0.000638	CcSEcCtD
Gallamine Triethiodide—Angioedema—Pregabalin—epilepsy syndrome	0.000116	0.000635	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000116	0.000635	CcSEcCtD
Gallamine Triethiodide—Confusional state—Valproic Acid—epilepsy syndrome	0.000116	0.000633	CcSEcCtD
Gallamine Triethiodide—Pruritus—Zonisamide—epilepsy syndrome	0.000116	0.000633	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000115	0.000631	CcSEcCtD
Gallamine Triethiodide—Urticaria—Lamotrigine—epilepsy syndrome	0.000115	0.000627	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000115	0.000627	CcSEcCtD
Gallamine Triethiodide—Malaise—Pregabalin—epilepsy syndrome	0.000114	0.000627	CcSEcCtD
Gallamine Triethiodide—Nausea—Propofol—epilepsy syndrome	0.000114	0.000627	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000114	0.000625	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Felbamate—epilepsy syndrome	0.000114	0.000625	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000114	0.000624	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000114	0.000624	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Gabapentin—epilepsy syndrome	0.000114	0.000624	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Pregabalin—epilepsy syndrome	0.000114	0.000622	CcSEcCtD
Gallamine Triethiodide—Rash—Fosphenytoin—epilepsy syndrome	0.000113	0.00062	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000113	0.00062	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Topiramate—epilepsy syndrome	0.000113	0.000619	CcSEcCtD
Gallamine Triethiodide—Asthenia—Clonazepam—epilepsy syndrome	0.000113	0.000618	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Topiramate—epilepsy syndrome	0.000113	0.000618	CcSEcCtD
Gallamine Triethiodide—Headache—Fosphenytoin—epilepsy syndrome	0.000113	0.000616	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Topiramate—epilepsy syndrome	0.000112	0.000616	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000112	0.000614	CcSEcCtD
Gallamine Triethiodide—Asthenia—Phenytoin—epilepsy syndrome	0.000112	0.000614	CcSEcCtD
Gallamine Triethiodide—Nausea—Midazolam—epilepsy syndrome	0.000112	0.000613	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000112	0.000613	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Valproic Acid—epilepsy syndrome	0.000112	0.000612	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000112	0.000612	CcSEcCtD
Gallamine Triethiodide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000112	0.000611	CcSEcCtD
Gallamine Triethiodide—Pruritus—Clonazepam—epilepsy syndrome	0.000111	0.00061	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vigabatrin—epilepsy syndrome	0.000111	0.00061	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Valproic Acid—epilepsy syndrome	0.000111	0.00061	CcSEcCtD
Gallamine Triethiodide—Cough—Pregabalin—epilepsy syndrome	0.000111	0.000607	CcSEcCtD
Gallamine Triethiodide—Pruritus—Phenytoin—epilepsy syndrome	0.000111	0.000606	CcSEcCtD
Gallamine Triethiodide—Nausea—Levetiracetam—epilepsy syndrome	0.000111	0.000605	CcSEcCtD
Gallamine Triethiodide—Rash—Vigabatrin—epilepsy syndrome	0.00011	0.000604	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vigabatrin—epilepsy syndrome	0.00011	0.000604	CcSEcCtD
Gallamine Triethiodide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00011	0.000602	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00011	0.000602	CcSEcCtD
Gallamine Triethiodide—Headache—Vigabatrin—epilepsy syndrome	0.00011	0.000601	CcSEcCtD
Gallamine Triethiodide—Vomiting—Diazepam—epilepsy syndrome	0.00011	0.0006	CcSEcCtD
Gallamine Triethiodide—Rash—Diazepam—epilepsy syndrome	0.000109	0.000595	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Diazepam—epilepsy syndrome	0.000109	0.000595	CcSEcCtD
Gallamine Triethiodide—Chest pain—Pregabalin—epilepsy syndrome	0.000108	0.000592	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Pregabalin—epilepsy syndrome	0.000108	0.000592	CcSEcCtD
Gallamine Triethiodide—Headache—Diazepam—epilepsy syndrome	0.000108	0.000591	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000108	0.00059	CcSEcCtD
Gallamine Triethiodide—Anaemia—Gabapentin—epilepsy syndrome	0.000108	0.000589	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000107	0.000588	CcSEcCtD
Gallamine Triethiodide—Asthenia—Carbamazepine—epilepsy syndrome	0.000107	0.000586	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000107	0.000586	CcSEcCtD
Gallamine Triethiodide—Nausea—Fosphenytoin—epilepsy syndrome	0.000107	0.000584	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000106	0.000583	CcSEcCtD
Gallamine Triethiodide—Angioedema—Gabapentin—epilepsy syndrome	0.000106	0.000582	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000106	0.000582	CcSEcCtD
Gallamine Triethiodide—Vomiting—Felbamate—epilepsy syndrome	0.000106	0.000581	CcSEcCtD
Gallamine Triethiodide—Pruritus—Carbamazepine—epilepsy syndrome	0.000106	0.000578	CcSEcCtD
Gallamine Triethiodide—Rash—Felbamate—epilepsy syndrome	0.000105	0.000576	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Topiramate—epilepsy syndrome	0.000105	0.000576	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Felbamate—epilepsy syndrome	0.000105	0.000575	CcSEcCtD
Gallamine Triethiodide—Malaise—Gabapentin—epilepsy syndrome	0.000105	0.000575	CcSEcCtD
Gallamine Triethiodide—Headache—Felbamate—epilepsy syndrome	0.000105	0.000572	CcSEcCtD
Gallamine Triethiodide—Confusional state—Pregabalin—epilepsy syndrome	0.000104	0.000572	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000104	0.000572	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Topiramate—epilepsy syndrome	0.000104	0.000572	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Gabapentin—epilepsy syndrome	0.000104	0.000571	CcSEcCtD
Gallamine Triethiodide—Nausea—Vigabatrin—epilepsy syndrome	0.000104	0.000569	CcSEcCtD
Gallamine Triethiodide—Vomiting—Zonisamide—epilepsy syndrome	0.000104	0.000569	CcSEcCtD
Gallamine Triethiodide—Asthenia—Lamotrigine—epilepsy syndrome	0.000103	0.000567	CcSEcCtD
Gallamine Triethiodide—Rash—Zonisamide—epilepsy syndrome	0.000103	0.000564	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000103	0.000563	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Zonisamide—epilepsy syndrome	0.000103	0.000563	CcSEcCtD
Gallamine Triethiodide—Nausea—Diazepam—epilepsy syndrome	0.000102	0.000561	CcSEcCtD
Gallamine Triethiodide—Headache—Zonisamide—epilepsy syndrome	0.000102	0.00056	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000102	0.000559	CcSEcCtD
Gallamine Triethiodide—Pruritus—Lamotrigine—epilepsy syndrome	0.000102	0.000559	CcSEcCtD
Gallamine Triethiodide—Cough—Gabapentin—epilepsy syndrome	0.000102	0.000556	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000101	0.000555	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Pregabalin—epilepsy syndrome	0.000101	0.000554	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Pregabalin—epilepsy syndrome	0.000101	0.000551	CcSEcCtD
Gallamine Triethiodide—Vomiting—Clonazepam—epilepsy syndrome	0.0001	0.000548	CcSEcCtD
Gallamine Triethiodide—Vomiting—Phenytoin—epilepsy syndrome	9.94e-05	0.000544	CcSEcCtD
Gallamine Triethiodide—Rash—Clonazepam—epilepsy syndrome	9.92e-05	0.000543	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Clonazepam—epilepsy syndrome	9.91e-05	0.000543	CcSEcCtD
Gallamine Triethiodide—Chest pain—Gabapentin—epilepsy syndrome	9.91e-05	0.000543	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Gabapentin—epilepsy syndrome	9.91e-05	0.000543	CcSEcCtD
Gallamine Triethiodide—Nausea—Felbamate—epilepsy syndrome	9.91e-05	0.000543	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.89e-05	0.000542	CcSEcCtD
Gallamine Triethiodide—Vomiting—Oxcarbazepine—epilepsy syndrome	9.89e-05	0.000541	CcSEcCtD
Gallamine Triethiodide—Fatigue—Valproic Acid—epilepsy syndrome	9.88e-05	0.000541	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Lamotrigine—epilepsy syndrome	9.87e-05	0.00054	CcSEcCtD
Gallamine Triethiodide—Headache—Clonazepam—epilepsy syndrome	9.86e-05	0.00054	CcSEcCtD
Gallamine Triethiodide—Rash—Phenytoin—epilepsy syndrome	9.86e-05	0.00054	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Phenytoin—epilepsy syndrome	9.85e-05	0.000539	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.84e-05	0.000539	CcSEcCtD
Gallamine Triethiodide—Rash—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.000537	CcSEcCtD
Gallamine Triethiodide—Pain—Valproic Acid—epilepsy syndrome	9.8e-05	0.000537	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.000536	CcSEcCtD
Gallamine Triethiodide—Headache—Phenytoin—epilepsy syndrome	9.79e-05	0.000536	CcSEcCtD
Gallamine Triethiodide—Headache—Oxcarbazepine—epilepsy syndrome	9.74e-05	0.000533	CcSEcCtD
Gallamine Triethiodide—Nausea—Zonisamide—epilepsy syndrome	9.7e-05	0.000531	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Topiramate—epilepsy syndrome	9.59e-05	0.000525	CcSEcCtD
Gallamine Triethiodide—Confusional state—Gabapentin—epilepsy syndrome	9.58e-05	0.000525	CcSEcCtD
Gallamine Triethiodide—Vomiting—Carbamazepine—epilepsy syndrome	9.49e-05	0.00052	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.44e-05	0.000517	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.44e-05	0.000517	CcSEcCtD
Gallamine Triethiodide—Rash—Carbamazepine—epilepsy syndrome	9.41e-05	0.000515	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Carbamazepine—epilepsy syndrome	9.4e-05	0.000515	CcSEcCtD
Gallamine Triethiodide—Nausea—Clonazepam—epilepsy syndrome	9.35e-05	0.000512	CcSEcCtD
Gallamine Triethiodide—Headache—Carbamazepine—epilepsy syndrome	9.35e-05	0.000512	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Pregabalin—epilepsy syndrome	9.3e-05	0.000509	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.3e-05	0.000509	CcSEcCtD
Gallamine Triethiodide—Nausea—Phenytoin—epilepsy syndrome	9.29e-05	0.000508	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Gabapentin—epilepsy syndrome	9.27e-05	0.000508	CcSEcCtD
Gallamine Triethiodide—Nausea—Oxcarbazepine—epilepsy syndrome	9.24e-05	0.000506	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gabapentin—epilepsy syndrome	9.23e-05	0.000505	CcSEcCtD
Gallamine Triethiodide—Vomiting—Lamotrigine—epilepsy syndrome	9.17e-05	0.000502	CcSEcCtD
Gallamine Triethiodide—Urticaria—Valproic Acid—epilepsy syndrome	9.1e-05	0.000499	CcSEcCtD
Gallamine Triethiodide—Rash—Lamotrigine—epilepsy syndrome	9.09e-05	0.000498	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Lamotrigine—epilepsy syndrome	9.08e-05	0.000497	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Valproic Acid—epilepsy syndrome	9.06e-05	0.000496	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Valproic Acid—epilepsy syndrome	9.06e-05	0.000496	CcSEcCtD
Gallamine Triethiodide—Anaemia—Topiramate—epilepsy syndrome	9.05e-05	0.000496	CcSEcCtD
Gallamine Triethiodide—Headache—Lamotrigine—epilepsy syndrome	9.03e-05	0.000495	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.94e-05	0.00049	CcSEcCtD
Gallamine Triethiodide—Fatigue—Pregabalin—epilepsy syndrome	8.93e-05	0.000489	CcSEcCtD
Gallamine Triethiodide—Nausea—Carbamazepine—epilepsy syndrome	8.86e-05	0.000485	CcSEcCtD
Gallamine Triethiodide—Pain—Pregabalin—epilepsy syndrome	8.86e-05	0.000485	CcSEcCtD
Gallamine Triethiodide—Malaise—Topiramate—epilepsy syndrome	8.83e-05	0.000484	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Topiramate—epilepsy syndrome	8.77e-05	0.00048	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.66e-05	0.000474	CcSEcCtD
Gallamine Triethiodide—Nausea—Lamotrigine—epilepsy syndrome	8.57e-05	0.000469	CcSEcCtD
Gallamine Triethiodide—Cough—Topiramate—epilepsy syndrome	8.55e-05	0.000468	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Pregabalin—epilepsy syndrome	8.54e-05	0.000468	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gabapentin—epilepsy syndrome	8.53e-05	0.000467	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.44e-05	0.000462	CcSEcCtD
Gallamine Triethiodide—Chest pain—Topiramate—epilepsy syndrome	8.34e-05	0.000457	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Topiramate—epilepsy syndrome	8.34e-05	0.000457	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.28e-05	0.000453	CcSEcCtD
Gallamine Triethiodide—Urticaria—Pregabalin—epilepsy syndrome	8.23e-05	0.000451	CcSEcCtD
Gallamine Triethiodide—Asthenia—Valproic Acid—epilepsy syndrome	8.22e-05	0.00045	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.2e-05	0.000449	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gabapentin—epilepsy syndrome	8.19e-05	0.000449	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Pregabalin—epilepsy syndrome	8.19e-05	0.000448	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Pregabalin—epilepsy syndrome	8.19e-05	0.000448	CcSEcCtD
Gallamine Triethiodide—Pain—Gabapentin—epilepsy syndrome	8.12e-05	0.000445	CcSEcCtD
Gallamine Triethiodide—Pruritus—Valproic Acid—epilepsy syndrome	8.11e-05	0.000444	CcSEcCtD
Gallamine Triethiodide—Confusional state—Topiramate—epilepsy syndrome	8.06e-05	0.000441	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Valproic Acid—epilepsy syndrome	7.84e-05	0.000429	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gabapentin—epilepsy syndrome	7.83e-05	0.000429	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Topiramate—epilepsy syndrome	7.83e-05	0.000429	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Topiramate—epilepsy syndrome	7.8e-05	0.000427	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Topiramate—epilepsy syndrome	7.76e-05	0.000425	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Pregabalin—epilepsy syndrome	7.63e-05	0.000418	CcSEcCtD
Gallamine Triethiodide—Urticaria—Gabapentin—epilepsy syndrome	7.55e-05	0.000413	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gabapentin—epilepsy syndrome	7.51e-05	0.000411	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Gabapentin—epilepsy syndrome	7.51e-05	0.000411	CcSEcCtD
Gallamine Triethiodide—Asthenia—Pregabalin—epilepsy syndrome	7.43e-05	0.000407	CcSEcCtD
Gallamine Triethiodide—Pruritus—Pregabalin—epilepsy syndrome	7.33e-05	0.000401	CcSEcCtD
Gallamine Triethiodide—Vomiting—Valproic Acid—epilepsy syndrome	7.29e-05	0.000399	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.28e-05	0.000399	CcSEcCtD
Gallamine Triethiodide—Rash—Valproic Acid—epilepsy syndrome	7.23e-05	0.000396	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Valproic Acid—epilepsy syndrome	7.22e-05	0.000395	CcSEcCtD
Gallamine Triethiodide—Headache—Valproic Acid—epilepsy syndrome	7.18e-05	0.000393	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Topiramate—epilepsy syndrome	7.18e-05	0.000393	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Pregabalin—epilepsy syndrome	7.09e-05	0.000388	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Gabapentin—epilepsy syndrome	7e-05	0.000383	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.9e-05	0.000378	CcSEcCtD
Gallamine Triethiodide—Fatigue—Topiramate—epilepsy syndrome	6.89e-05	0.000377	CcSEcCtD
Gallamine Triethiodide—Pain—Topiramate—epilepsy syndrome	6.83e-05	0.000374	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gabapentin—epilepsy syndrome	6.82e-05	0.000373	CcSEcCtD
Gallamine Triethiodide—Nausea—Valproic Acid—epilepsy syndrome	6.81e-05	0.000373	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gabapentin—epilepsy syndrome	6.72e-05	0.000368	CcSEcCtD
Gallamine Triethiodide—Vomiting—Pregabalin—epilepsy syndrome	6.59e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Topiramate—epilepsy syndrome	6.59e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Rash—Pregabalin—epilepsy syndrome	6.53e-05	0.000358	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Pregabalin—epilepsy syndrome	6.53e-05	0.000357	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gabapentin—epilepsy syndrome	6.5e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Headache—Pregabalin—epilepsy syndrome	6.49e-05	0.000355	CcSEcCtD
Gallamine Triethiodide—Urticaria—Topiramate—epilepsy syndrome	6.35e-05	0.000348	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Topiramate—epilepsy syndrome	6.32e-05	0.000346	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Topiramate—epilepsy syndrome	6.32e-05	0.000346	CcSEcCtD
Gallamine Triethiodide—Nausea—Pregabalin—epilepsy syndrome	6.15e-05	0.000337	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gabapentin—epilepsy syndrome	6.04e-05	0.000331	CcSEcCtD
Gallamine Triethiodide—Rash—Gabapentin—epilepsy syndrome	5.99e-05	0.000328	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gabapentin—epilepsy syndrome	5.98e-05	0.000328	CcSEcCtD
Gallamine Triethiodide—Headache—Gabapentin—epilepsy syndrome	5.95e-05	0.000326	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Topiramate—epilepsy syndrome	5.89e-05	0.000322	CcSEcCtD
Gallamine Triethiodide—Asthenia—Topiramate—epilepsy syndrome	5.73e-05	0.000314	CcSEcCtD
Gallamine Triethiodide—Pruritus—Topiramate—epilepsy syndrome	5.65e-05	0.00031	CcSEcCtD
Gallamine Triethiodide—Nausea—Gabapentin—epilepsy syndrome	5.64e-05	0.000309	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Topiramate—epilepsy syndrome	5.47e-05	0.000299	CcSEcCtD
Gallamine Triethiodide—Vomiting—Topiramate—epilepsy syndrome	5.08e-05	0.000278	CcSEcCtD
Gallamine Triethiodide—Rash—Topiramate—epilepsy syndrome	5.04e-05	0.000276	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Topiramate—epilepsy syndrome	5.03e-05	0.000276	CcSEcCtD
Gallamine Triethiodide—Headache—Topiramate—epilepsy syndrome	5.01e-05	0.000274	CcSEcCtD
Gallamine Triethiodide—Nausea—Topiramate—epilepsy syndrome	4.75e-05	0.00026	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM3—epilepsy syndrome	3.26e-05	0.000302	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM4—epilepsy syndrome	3.26e-05	0.000302	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—BCHE—epilepsy syndrome	3.25e-05	0.000301	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR2—epilepsy syndrome	3.22e-05	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SST—epilepsy syndrome	3.22e-05	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	3.21e-05	0.000297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ST3GAL3—epilepsy syndrome	3.2e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SSTR2—epilepsy syndrome	3.2e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGT—epilepsy syndrome	3.19e-05	0.000295	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	3.18e-05	0.000295	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRA2A—epilepsy syndrome	3.15e-05	0.000292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR3—epilepsy syndrome	3.15e-05	0.000291	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADSL—epilepsy syndrome	3.14e-05	0.00029	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	3.12e-05	0.000288	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRDM4—epilepsy syndrome	3.11e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRICKLE1—epilepsy syndrome	3.11e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM8—epilepsy syndrome	3.09e-05	0.000286	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GLUL—epilepsy syndrome	3.08e-05	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL12—epilepsy syndrome	3.03e-05	0.00028	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—BDKRB2—epilepsy syndrome	3.03e-05	0.00028	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CACNA1D—epilepsy syndrome	3.02e-05	0.00028	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ARHGEF9—epilepsy syndrome	3.02e-05	0.000279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR9—epilepsy syndrome	3.02e-05	0.000279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPY2R—epilepsy syndrome	3.02e-05	0.000279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR1—epilepsy syndrome	3.02e-05	0.000279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR8—epilepsy syndrome	3.02e-05	0.000279	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.01e-05	0.000278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—epilepsy syndrome	2.97e-05	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM3—epilepsy syndrome	2.96e-05	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM4—epilepsy syndrome	2.96e-05	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OPRD1—epilepsy syndrome	2.95e-05	0.000273	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.93e-05	0.000271	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR2—epilepsy syndrome	2.91e-05	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR7—epilepsy syndrome	2.9e-05	0.000268	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLAUR—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TXNRD1—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDYN—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CHRM1—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM1—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR7—epilepsy syndrome	2.83e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM8—epilepsy syndrome	2.81e-05	0.00026	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.76e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.76e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AQP1—epilepsy syndrome	2.74e-05	0.000254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.73e-05	0.000252	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ACKR4—epilepsy syndrome	2.71e-05	0.000251	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—POMC—epilepsy syndrome	2.68e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OPRD1—epilepsy syndrome	2.68e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNAO1—epilepsy syndrome	2.68e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.68e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	2.67e-05	0.000247	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAL—epilepsy syndrome	2.66e-05	0.000246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.64e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM5—epilepsy syndrome	2.63e-05	0.000243	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CHRM3—epilepsy syndrome	2.63e-05	0.000243	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CHRM1—epilepsy syndrome	2.57e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDYN—epilepsy syndrome	2.57e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR7—epilepsy syndrome	2.57e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM1—epilepsy syndrome	2.57e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	2.53e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.51e-05	0.000232	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CHRM3—epilepsy syndrome	2.48e-05	0.00023	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—KCNJ11—epilepsy syndrome	2.48e-05	0.00023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—BDKRB1—epilepsy syndrome	2.47e-05	0.000229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR4—epilepsy syndrome	2.45e-05	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR5—epilepsy syndrome	2.45e-05	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AVP—epilepsy syndrome	2.44e-05	0.000226	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAL—epilepsy syndrome	2.41e-05	0.000223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GABBR1—epilepsy syndrome	2.4e-05	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM5—epilepsy syndrome	2.39e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CHRM3—epilepsy syndrome	2.39e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR10—epilepsy syndrome	2.35e-05	0.000218	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.34e-05	0.000216	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.31e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HRH3—epilepsy syndrome	2.3e-05	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CR1—epilepsy syndrome	2.29e-05	0.000212	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OPRM1—epilepsy syndrome	2.27e-05	0.00021	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.26e-05	0.000209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—BDKRB1—epilepsy syndrome	2.24e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CL1—epilepsy syndrome	2.24e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GABBR1—epilepsy syndrome	2.18e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR3—epilepsy syndrome	2.14e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	2.13e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRH3—epilepsy syndrome	2.09e-05	0.000194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPY—epilepsy syndrome	2.09e-05	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	2.09e-05	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR5—epilepsy syndrome	2.08e-05	0.000192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OPRM1—epilepsy syndrome	2.06e-05	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM2—epilepsy syndrome	2.06e-05	0.00019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—epilepsy syndrome	2.03e-05	0.000188	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG2—epilepsy syndrome	2.02e-05	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CRH—epilepsy syndrome	2.01e-05	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OXT—epilepsy syndrome	2.01e-05	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL2—epilepsy syndrome	2.01e-05	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2e-05	0.000185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—epilepsy syndrome	2e-05	0.000185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2C19—epilepsy syndrome	1.97e-05	0.000182	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP11A1—epilepsy syndrome	1.96e-05	0.000181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR3—epilepsy syndrome	1.95e-05	0.00018	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.95e-05	0.00018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—epilepsy syndrome	1.93e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPY—epilepsy syndrome	1.9e-05	0.000175	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.87e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR3—epilepsy syndrome	1.86e-05	0.000172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OXT—epilepsy syndrome	1.83e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CRH—epilepsy syndrome	1.83e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL3—epilepsy syndrome	1.83e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL2—epilepsy syndrome	1.83e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR2—epilepsy syndrome	1.82e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SST—epilepsy syndrome	1.82e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.82e-05	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR9—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY2R—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR8—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR1—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.78e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.77e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2D6—epilepsy syndrome	1.77e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM4—epilepsy syndrome	1.75e-05	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM3—epilepsy syndrome	1.75e-05	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR2—epilepsy syndrome	1.72e-05	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DUSP4—epilepsy syndrome	1.72e-05	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.71e-05	0.000158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.71e-05	0.000158	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADRA2A—epilepsy syndrome	1.68e-05	0.000156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.68e-05	0.000156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—POMC—epilepsy syndrome	1.68e-05	0.000156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BCHE—epilepsy syndrome	1.68e-05	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.68e-05	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	1.66e-05	0.000153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	1.66e-05	0.000153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	1.65e-05	0.000153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	1.65e-05	0.000153	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.64e-05	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.64e-05	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	1.62e-05	0.00015	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.62e-05	0.00015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A1—epilepsy syndrome	1.6e-05	0.000148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	1.59e-05	0.000147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLCB1—epilepsy syndrome	1.58e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	1.58e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	1.58e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TH—epilepsy syndrome	1.58e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	1.56e-05	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	1.56e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.56e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.55e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	1.53e-05	0.000141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.52e-05	0.000141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	1.52e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	1.52e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	1.52e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	1.52e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	1.49e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.45e-05	0.000134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.43e-05	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	1.43e-05	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	1.43e-05	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	1.42e-05	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	1.41e-05	0.00013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	1.41e-05	0.00013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	1.41e-05	0.00013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.38e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.35e-05	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.33e-05	0.000123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.33e-05	0.000123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—epilepsy syndrome	1.32e-05	0.000122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAT—epilepsy syndrome	1.3e-05	0.00012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.29e-05	0.00012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.29e-05	0.000119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—epilepsy syndrome	1.26e-05	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.25e-05	0.000116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.24e-05	0.000114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.22e-05	0.000113	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—epilepsy syndrome	1.17e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.17e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.15e-05	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.15e-05	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.12e-05	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.12e-05	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.09e-05	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.08e-05	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.08e-05	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.08e-05	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.08e-05	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.08e-05	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.07e-05	9.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.04e-05	9.65e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—epilepsy syndrome	1.03e-05	9.52e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—epilepsy syndrome	1.01e-05	9.33e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.01e-05	9.32e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1e-05	9.29e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1e-05	9.29e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	9.9e-06	9.16e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	9.77e-06	9.04e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	9.77e-06	9.04e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	9.77e-06	9.04e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	9.69e-06	8.96e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.56e-06	8.85e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	9.52e-06	8.81e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.19e-06	8.5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	9.19e-06	8.5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	9.17e-06	8.49e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.15e-06	8.46e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.11e-06	8.43e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	9.02e-06	8.34e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	9.02e-06	8.34e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	8.99e-06	8.31e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	8.8e-06	8.14e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—POMC—epilepsy syndrome	8.66e-06	8.01e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	8.54e-06	7.9e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	8.38e-06	7.76e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	8.33e-06	7.71e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	8.19e-06	7.58e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	8.15e-06	7.54e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—epilepsy syndrome	7.9e-06	7.31e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	7.74e-06	7.16e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	7.67e-06	7.09e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	7.65e-06	7.08e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	7.41e-06	6.85e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	7e-06	6.48e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—epilepsy syndrome	6.91e-06	6.39e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.81e-06	6.3e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.79e-06	6.28e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.77e-06	6.27e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.55e-06	6.06e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	6.47e-06	5.99e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	6.3e-06	5.83e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	6.16e-06	5.7e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	5.85e-06	5.42e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	5.85e-06	5.41e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.73e-06	5.3e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.61e-06	5.19e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.4e-06	5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.38e-06	4.98e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.92e-06	4.55e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.82e-06	4.45e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.35e-06	4.03e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.04e-06	3.74e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.96e-06	3.66e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.68e-06	3.4e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.64e-06	3.37e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.54e-06	3.27e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—epilepsy syndrome	3.47e-06	3.21e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.44e-06	3.19e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.34e-06	3.09e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.17e-06	2.94e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.09e-06	2.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.97e-06	1.83e-05	CbGpPWpGaD
